McManus Group

Campaign Finance

$78,450 Given
Information

Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:

  • contributions under $200 are not reported, and so are not included in totals.
  • only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
  • contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
  • corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
  • organization totals include known subsidiaries of the organization.

For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.

  • Top Recipients

    PAC Color Block
    Organization's PAC(s)
    Employee Color Block
    Associated Individuals
    Includes contributions from the organization’s employees, their family members, and its political action committee.
  • Republicans vs. Democrats

    in dollars
  • State vs. Federal

    in dollars
  • Top PAC Recipients

    PAC Color Block
    Organization's PAC(s)
    Employee Color Block
    Associated Individuals
    Includes contributions from the organization’s employees, their family members, and its political action committee.
View all campaign finance data for McManus Group Sources: OpenSecrets.org

Lobbying

$5,250,000 Income
Information

Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.

For more information, please see our lobbying methodology page.

Lobbying Carried Out by McManus Group

  • Names of Lobbyists
  • Client Amount
    Amgen Inc $560,000
    Eli Lilly & Co $480,000
    American Medical Assn $480,000
    Genentech Inc $460,000
    Large Urology Group Practice Assn $460,000
    Allergan Inc $460,000
    Spiracur $340,000
    Pharmaceutical Rsrch & Mfrs of America $320,000
    Evolution1 Inc $320,000
    ASC Advocacy Cmte $300,000
  • Most Frequently Disclosed Lobbying Issues
    • Medicare & Medicaid,
    • Health Issues,
    • Taxes,
    • Copyright, Patent & Trademark,
    • Finance,
    • Torts,
    • Radio & TV Broadcasting,
    • Trade
  • Most Frequently Disclosed Bills
    Bill No. Title
    H.R.436 Protect Medical Innovation Act of 2011
    H.R.452 Medicare Decisions Accountability Act of 2011
    S.668 Health Care Bureaucrats Elimination Act
    S.3187 Food and Drug Administration Safety and Innovation Act
    H.R.1004 Medical FSA Improvement Act of 2011
    S.17 Medical Device Access and Innovation Protection Act
    H.R.2108 Ambulatory Surgical Center Quality and Access Act of 2011
    S.1173 Ambulatory Surgical Center Quality and Access Act of 2011
    H.R.1249 America Invents Act
    H.R.1546 Medicare Access to Rehabilitation Services Act of 2011
  • Recent Lobbying Contracts
    Date Client Summary
    Jan. 20, 2015 XOMA Corporation General health care coverage and reimbursement; issues related to ophthalmology and oncology drug development; Food and Drug Administration legislative and regulatory issues including orphan drug policy. View registration
    Jan. 20, 2015 Tetraphase Pharmaceuticals General health care coverage and reimbursement; Food and Drug Administration legislative and regulatory issues; and implementation of Health Care Reform PL 111-148, Patient Protection and Affordable Care Act. View registration
    Jan. 20, 2015 Zavante Therapeutics, Inc. General health care coverage and reimbursement; Food and Drug Administration legislative and regulatory issues; and implementation of Health Care Reform PL 111-148, Patient Protection and Affordable Care Act. View registration
    Jan. 20, 2015 Microbion Corporation General health care coverage and reimbursement; Food and Drug Administration legislative and regulatory issues; and implementation of Health Care Reform PL 111-148, Patient Protection and Affordable Care Act. View registration
View all lobbying data for McManus Group Sources: Lobbyist Registration Tracker OpenSecrets.org

Regulations

Information

All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.

Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.

Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.

Regulations and public comments can be downloaded in bulk here.

updated daily from Regulations.gov by way of Docket Wrench

The tables show occurrences of "McManus Group" in public comments on proposed federal regulations.